ConductScience.org, home

Comparison · NCT03477006-3194d374

LTLR-WB vs Standard Care: 28 Day All Cause Mortality

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. LTLR-WB vs Standard Care: 28 Day All Cause Mortality. Trial comparisons, record NCT03477006-3194d374. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03477006-3194d374

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.250.1420.402wilson
Risk in group 20.2610.1560.403wilson
Risk difference, group 1 minus group 2-0.0109-0.1890.174newcombe hybrid score
Risk ratio, group 1 over group 20.9580.4641.98log
Odds ratio, group 1 over group 20.9440.3572.5log
Number needed to treat, for one fewer participant with the outcome on LTLR-WB than on Standard Care92from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: standard care.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1LTLR-WB
Receiving 2 units of low titer, leucocyte reduced, platelet replete whole blood initiated in the prehospital setting during air medical transport and continued (up to 6 units of whole blood followed by standard component resuscitation) thru the early in-hospital phase of care~Whole blood: Low titer, group O, leukocyte reduced, platelet replete, cold stored whole blood
1040OG000
Group 2Standard CareReceiving standard prehospital air medical care and standard of care component (1:1:1) trauma resuscitation thru the early in-hospital phase of care1246OG001

Outcome

Type
PRIMARY
Title
28 Day All Cause Mortality
Description
28 day all cause mortality
Time frame
28 days from admission
Population

Source ClinicalTrials.gov

Trial

Title
Pragmatic Prehospital Group O Whole Blood Early Resuscitation Trial
NCT number
NCT03477006
Phases
PHASE3
Conditions
Hemorrhagic Shock
Interventions
Whole blood
Lead sponsor
Jason Sperry
Results first posted
2021-10-06

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT03477006-3194d374